Bright Minds Biosciences Inc. Board of Directors

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.

Mr. Ian McDonald

Mr. Ian McDonald

Co-Founder, CEO, President & Director

Mr. Alex Vasilkevich

Mr. Alex Vasilkevich

COO & VP of Corporate Development

Dr. Jan Torleif Pedersen M.Sc., Ph.D.

Dr. Jan Torleif Pedersen M.Sc., Ph.D.

Chief Science Officer & Director

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.